Differential BDNF responses of triple versus dual reuptake inhibition in neuronal and astrocytoma cells as well as in rat hippocampus and prefrontal cortex

Journal of Molecular Neuroscience

Volumn 48, Issue 1, 2012, Pages 167-175

  Prickaerts, Jos ^a   De Vry, Jochen ^a   Boere, Janneke ^a,b   Kenis, Gunter ^a   Quinton, Maria S ^b   Engel, Sharon ^b   Melnick, Larry ^b   Schreiber, Rudy ^b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b SUNOVION PHARMACEUTICALS INC   (United States)

^c EVOTEC AG   (Germany)

Author keywords

Astrocytes; BDNF; DOV 216,303; Duloxetine; Neurons

Indexed keywords

AMITIFADINE; BRAIN DERIVED NEUROTROPHIC FACTOR; DULOXETINE;

ARTICLE; ASTROCYTOMA; ASTROCYTOMA CELL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; NERVE CELL; NONHUMAN; PREFRONTAL CORTEX; PROTEIN FUNCTION; RAT; STRESS;

ANIMALS; ANTIDEPRESSIVE AGENTS; ASTROCYTES; ASTROCYTOMA; AZA COMPOUNDS; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN NEOPLASMS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE, TUMOR; DEPRESSIVE DISORDER; HIPPOCAMPUS; MALE; MICE; NEURONS; NEUROTRANSMITTER UPTAKE INHIBITORS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; THIOPHENES;

MURINAE; RATTUS;

EID: 84865138269     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-012-9802-9     Document Type: Article

References (53)

1. Adachi M, Barrot M, Autry AE, Theobald D, Monteggia LM (2008) Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry 63(7):642-649 (Pubitemid 351329281)
2. Allaman I, Fiumelli H, Magistretti PJ, Martin JL (2011) Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology (Berl) 216(1):75-84
3. Balu DT, Hoshaw BA, Malberg JE, Rosenzweig-Lipson S, Schechter LE, Lucki I (2008) Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Res 1211:37-43
4. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311(5762):864-868 (Pubitemid 43228853)
5. Boldrini M, Underwood MD, Hen R, Rosoklija GB, Dwork AJ, John Mann J, Arango V (2009) Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 34(11):2376-2389
6. Breuer ME, Chan JS, Oosting RS, Groenink L, Korte SM, Campbell U, Schreiber R, Hanania T, Snoeren EM, Waldinger M, Olivier B (2008) The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects. Eur Neuropsychopharmacol 18(12):908-916
7. Calabrese F, Molteni R, Maj PF, Cattaneo A, Gennarelli M, Racagni G, Riva MA (2007) Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 32(11):2351-2359 (Pubitemid 47587673)
8. Calabrese F, Molteni R, Cattaneo A, Macchi F, Racagni G, Gennarelli M, Ellenbroek BA, Riva MA (2010) Long-term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. Mol Pharmacol 77(5):846-853
9. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50(4):260-265 (Pubitemid 32778442)
10. Chourbaji S, Brandwein C, Gass P (2010) Altering BDNF expression by genetics and/or environment: impact for emotional and depression-like behaviour in laboratory mice. Neurosci Biobehav Rev 35:599-611
11. Cooke JD, Grover LM, Spangler PR (2009) Venlafaxine treatment stimulates expression of brain-derived neurotrophic factor protein in frontal cortex and inhibits long-term potentiation in hippocampus. Neuroscience 162(4):1411-1419
12. Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP (2002) Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 12(4):386-394 (Pubitemid 34226063)
13. Czeh B, Muller-Keuker JI, Rygula R, Abumaria N, Hiemke C, Domenici E, Fuchs E (2007) Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology 32(7):1490-1503 (Pubitemid 46920152)
14. David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux JP, Artymyshyn RP, Gardier AM, Gerald C, Antonijevic IA, Leonardo ED, Hen R (2009) Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62(4):479-493
15. Duman RS, Malberg J, Nakagawa S, D'Sa C (2000) Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48(8):732-739
16. Eisch AJ, Bolanos CA, de Wit J, Simonak RD, Pudiak CM, Barrot M, Verhaagen J, Nestler EJ (2003) Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 54(10):994-1005 (Pubitemid 37415034)
17. Gourley SL, Kiraly DD, Howell JL, Olausson P, Taylor JR (2008) Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone. Biol Psychiatry 64(10):884-890
18. Heiser P, Hausmann C, Frey J, Geller F, Becker R, Wesemann W, Krieg JC, Remschmidt H, Vedder H (2002) Serotonergic effects of clozapine and its metabolites in hippocampal HT22 cells. Psychiatry Res 112(3):221-229 (Pubitemid 35351723)
19. Hodes GE, Hill-Smith TE, Lucki I (2010) Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice. Neurosci Lett 484(1):12-16
20. Horner PJ, Palmer TD (2003) New roles for astrocytes: the nightlife of an 'astrocyte'. La vida loca! Trends Neurosci 26(11):597-603 (Pubitemid 37338367)
21. Jacobs BL, van Praag H, Gage FH (2000) Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 5(3):262-269 (Pubitemid 30438401)
22. Juric DM, Miklic S, Carman-Krzan M (2006) Monoaminergic neuronal activity up-regulates BDNF synthesis in cultured neonatal rat astrocytes. Brain Res 1108(1):54-62 (Pubitemid 44278004)
23. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R (2005) Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 136(1-2):29-37 (Pubitemid 40704606)
24. Katoh A, Eigyo M, Ishibashi C, Naitoh Y, Takeuchi M, Ibii N, Ikeda M, Matsushita A (1995) Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats. J Pharmacol Exp Ther 272(3):1067-1075
25. Khawaja X, Xu J, Liang JJ, Barrett JE (2004) Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: implications for depressive disorders and future therapies. J Neurosci Res 75(4):451-460 (Pubitemid 38160706)
26. Le R, Kermani P, Teng KK, Hempstead BL (2001) Regulation of cell survival by secreted proneurotrophins. Science 294(5548):1945-1948 (Pubitemid 33101595)
27. Lee J, Duan W, Mattson MP (2002) Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 82(6):1367-1375
28. Lengyel K, Pieschl R, Strong T, Molski T, Mattson G, Lodge NJ, Li YW (2008) Ex vivo assessment of binding site occupancy of monoamine reuptake inhibitors: methodology and biological significance. Neuropharmacology 55(1):63-70
29. Lu B, Pang PT, Woo NH (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci 6(8):603-614 (Pubitemid 41059335)
30. Lucassen PJ, Stumpel MW, Wang Q, Aronica E (2010) Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients. Neuropharmacology 58(6):940-949
31. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A (2000) Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 47(12):1043-1049 (Pubitemid 30336212)
32. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20(24):9104-9110 (Pubitemid 32042912)
33. Mannari C, Origlia N, Scatena A, Del Debbio A, Catena M, Dell'agnello G, Barraco A, Giovannini L, Dell'osso L, Domenici L, Piccinni A (2008) BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake. Cell Mol Neurobiol 28(3):457-468
34. Mercier G, Lennon AM, Renouf B, Dessouroux A, Ramauge M, Courtin F, Pierre M (2004) MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J Mol Neurosci 24(2):207-216 (Pubitemid 41359148)
35. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ (2007) Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 61(2):187-197 (Pubitemid 46072778)
36. Muller MB, Lucassen PJ, Yassouridis A, Hoogendijk WJ, Holsboer F, Swaab DF (2001) Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci 14(10):1603-1612 (Pubitemid 35478029)
37. Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15(11):7539-7547
38. Peng CH, Chiou SH, Chen SJ, Chou YC, Ku HH, Cheng CK, Yen CJ, Tsai TH, Chang YL, Kao CL (2008) Neuroprotection by imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway. Eur Neuropsychopharmacol 18(2):128-140 (Pubitemid 50016798)
39. Prickaerts J, van den Hove DL, Fierens FL, Kia HK, Lenaerts I, Steckler T (2006) Chronic corticosterone manipulations in mice affect brain cell proliferation rates, but only partly affect BDNF protein levels. Neurosci Lett 396(1):12-16 (Pubitemid 43233779)
40. Prins J, Westphal KG, Korte-Bouws GA, Quinton MS, Schreiber R, Olivier B, Korte SM (2011) The potential and limitations of DOV 216,303 as a triple reuptake inhibitor for the treatment of major depression: a microdialysis study in olfactory bulbectomized rats. Pharmacol Biochem Behav 97(3):444-452
41. Ransom B, Behar T, Nedergaard M (2003) New roles for astrocytes (stars at last). Trends Neurosci 26(10):520-522 (Pubitemid 37176905)
42. Sairanen M, Lucas G, Ernfors P, Castren M, Castren E (2005) Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 25(5):1089-1094 (Pubitemid 40268949)
43. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301(5634):805-809 (Pubitemid 36962615)
44. Schmidt P, Holsboer F, Spengler D (2001) Beta(2)-adrenergic receptors potentiate glucocorticoid receptor transactivation via G protein beta gamma-subunits and the phosphoinositide 3-kinase pathway. Mol Endocrinol 15(4):553-564 (Pubitemid 32324437)
45. Shimada S, Hirabayashi M, Ishige K, Kosuge Y, Kihara T, Ito Y (2010) Activation of dopamine D4 receptors is protective against hypoxia/reoxygenation- induced cell death in HT22 cells. J Pharmacol Sci 114(2):217-224
46. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22(8):3251-3261 (Pubitemid 35379212)
47. Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS (2003) "Broad spectrum" antidepressants: is more better for the treatment of depression? Life Sci 73(25):3175-3179 (Pubitemid 37237572)
48. Smith MA, Makino S, Kvetnansky R, Post RM (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15(3 Pt 1):1768-1777
49. Song H, Stevens CF, Gage FH (2002) Astroglia induce neurogenesis from adult neural stem cells. Nature 417(6884):39-44 (Pubitemid 34498810)
50. Troelsen KB, Nielsen EO, Mirza NR (2005) Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter. Psychopharmacology (Berl) 181(4):741-750 (Pubitemid 41400760)
51. Van der Heyden JA, Zethof TJ, Olivier B (1997) Stress-induced hyperthermia in singly housed mice. Physiol Behav 62(3):463-470 (Pubitemid 27376279)
52. Xu H, Qing H, Lu W, Keegan D, Richardson JS, Chlan-Fourney J, Li XM (2002) Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett 321(1-2):65-68 (Pubitemid 34185500)
53. Xu H, Chen Z, He J, Haimanot S, Li X, Dyck L, Li XM (2006) Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 16(6):551-559 (Pubitemid 43942103)